{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-000291","form_type":"8-K","ticker":"YCBD","cik":"0001644903","company_name":"cbdMD, Inc.","filed_at":"2025-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.288081+00:00","generated_at":"2026-05-28T14:28:58.185679+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"cbdMD receives additional NYSE American noncompliance notice for equity under $2M","bullets":["Stockholders' equity $1,963,417 as of Sep 30, 2024, below $2M threshold; losses in 4 of 5 recent fiscal years.","Plan accepted Aug 20, 2024 for prior equity deficiency; new deadline Dec 5, 2025 to regain compliance.","Company may seek shareholder approval to convert $4.67M Preferred Stock liability (incl. accrued dividends) into common equity.","Cash consumption reduced to $0.7M in fiscal 2024 from $4.9M in fiscal 2023; trading continues with \".BC\" designation."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-000291","json":"https://secwatch.observer/filing/0001437749-25-000291.json","markdown":"https://secwatch.observer/filing/0001437749-25-000291.md","text":"https://secwatch.observer/filing/0001437749-25-000291.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644903/000143774925000291/0001437749-25-000291-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644903/000143774925000291/ycbd20250103_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T14:28:58.185679+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5c586005e1a4305a74cac657113e26f707b1b483","claim":"cbdMD, Inc. received a nyse_american noncompliance notice notice regarding stockholders equity (rules 1003(a)(i)).","evidence_excerpt":"December 31, 2024, cbdMD, Inc. (the “Company”) received notification (the “Notice”) from the NYSE American LLC (the “NYSE American”) that the Company is no longer in compliance with an additional NYSE American continued","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1644903/000143774925000291/0001437749-25-000291-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nyse american"},{"label":"Notice","value":"noncompliance notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"1003(a)(i)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}